| Literature DB >> 29518971 |
Mina Cheraghi Nirumand1, Marziyeh Hajialyani2, Roja Rahimi3, Mohammad Hosein Farzaei4, Stéphane Zingue5,6, Seyed Mohammad Nabavi7, Anupam Bishayee8.
Abstract
Kidney stones are one of the oldest known and common diseases in the urinary tract system. Various human studies have suggested that diets with a higher intake of vegetables and fruits play a role in the prevention of kidney stones. In this review, we have provided an overview of these dietary plants, their main chemical constituents, and their possible mechanisms of action. Camellia sinensis (green tea), Rubus idaeus (raspberry), Rubia cordifolia (common madder), Petroselinum crispum (parsley), Punica granatum (pomegranate), Pistacia lentiscus (mastic), Solanum xanthocarpum (yellow-fruit nightshade), Urtica dioica (stinging nettle), Dolichos biflorus (horse gram), Ammi visnaga (khella), Nigella sativa (black-cumin), Hibiscus sabdariffa (roselle), and Origanum vulgare (oregano) have received considerable interest based on scientific evidence. Beside these dietary plants, phytochemicals-such as catechin, epicatechin, epigallocatechin-3-gallate, diosmin, rutin, quercetin, hyperoside, and curcumin-as antioxidant dietary phyto-phenols were found to be effective for the prevention of urolithiasis (the process of stone formation in the urinary tract). The main underlying mechanisms of these dietary plants and their isolated phytonutrients in the management of urolithiasis include diuretic, antispasmodic, and antioxidant activity, as well as an inhibitory effect on crystallization, nucleation, and aggregation of crystals. The results as presented in this review demonstrate the promising role of dietary plants and phytophenols in the prevention and management of kidney stones. Further investigations are required to confirm the safety and efficacy of these compounds.Entities:
Keywords: dietary plants; kidney stone; natural dietary supplement; nephrolithiasis; phytochemicals; urolithiasis
Mesh:
Substances:
Year: 2018 PMID: 29518971 PMCID: PMC5877626 DOI: 10.3390/ijms19030765
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Experimental and clinical evidence on nutritional plants used for prevention and treatment of kidney stones.
| Plant | Part of Plant | Study Type | Study Design | Results | Reference |
|---|---|---|---|---|---|
| Green tea ( | Leaves of kidney stones | In vivo | Ethylene glycol (EG)-induced nephrolithiasis in rat | ↓ Calcium crystal depositions in the kidneys | [ |
| Leaves | In vivo | EG-induced nephrolithiasis in rat | ↓ Urinary oxalate excretion, calcium oxalate deposit formation | [ | |
| Rasberry ( | Aqueous extract | In vivo | Glyoxylate-induced calcium oxalate (CaOx) nephrolithiasis in mice | ↓ Generation of malondialdehyde (MDA) and protein carbonyls | [ |
| Methanolic extract | In vivo | Bicarbonate saline solution (containing 110 mM NaCl and 30 mM NaHCO3) induced nephrolithiasis in rats | ↓ Activity of aldosterone or epithelial sodium channels | [ | |
| Common madder ( | Hydro-alcoholic extract | In vivo | EG-induced urolithiasis | ↓ The growth of calcium oxalate crystals | [ |
| Parsley ( | Ethanolic extract | In vivo | EG+ ammonium chloride (AlCl3)-induced urolithiasis in rat | ↓ Urinary calcium and protein excretion | [ |
| Aqueous Extract | In vivo | EG-induced urolithiasis in rats | ↓ Serum urea and uric acid concentrations | [ | |
| Parsley ( | Aerial parts and roots aqueous extract | In vivo | EG-feeding rats | ↓ The number of calcium oxalate deposits | [ |
| Pomegranate ( | Fruits chloroform and methanol extract | In vivo | EG-induced urolithiasis | ↓ Urine oxalate, calcium and phosphate, renal tissue oxalates | [ |
| Yellow-fruit nightshade ( | The methanolic extract | In vivo | EG-induced urolithiasis in rats | ↓ Renal hyperoxaluria and crystalluria, | [ |
| Stinging nettle ( | Methanolic extract | In vivo | EG-induced urolithiasis in rats | ↓ Urinary creatinine level and the supersaturation of lithogenic enhancing agents | [ |
| Aqueous extract of fruits | In vivo | EG+ aluminum chloride-induced urolithiasis in rats | ↓ Calcium oxalate crystal deposition | [ | |
| Black-cumin ( | Ethanolicextract of seeds | In vivo | Ethylene glycol for induction of calcium oxalate calculus formation in rats | ↓ Number of calcium oxalate deposits | [ |
| Thymoquinone (major component of seeds) | In vivo | Ethylene glycol-induced kidney calculi in rats | ↓ Number and size of calcium oxalate deposits in the renal tubules | [ | |
| Aqueous extract of unripe fruit | In vivo | EG -induced calcium oxalate crystallization | Preventing the formation of calcium oxalate nephrolithiasis and pathological alterations in rats | [ | |
| Oregano ( | Aerial part aqueous-methanolic extract | In vivo | EG-induced urolithiasis in rats | Preventing loss of body weight, polyurea, crystalluria, oxaluria | [ |
| Plant aqueous extracts | In vivo | EG-induced hyperoxaluria | ↓ Deposition of stone-forming constituents in the kidneys and serum | [ | |
| aqueous extract | In vitro | A flask containing a cystine stone | ↑ Dissolution rate of cystine stones | [ | |
| ethanolic fruit extract | In vitro | Calcium oxalate monohydrate-induced in Human Kidney (HK)-2 cells | ↓ Cell death induced by COM, | [ | |
| Roselle ( | Hydro-alcoholic extract of seeds | In vitro | Calcium oxalate crystallization using a synthetic urine system | ↓ Nucleation and aggregation of calcium oxalate monohydrate crystals | [ |
| Aqueous, chloroform, and benzene extracts of seed | In vitro | Experimental preparation of kidney stones; calcium oxalate and calcium phosphate | Dissolving calcium oxalate stones | [ | |
| Oregano ( | Crude aqueous-methanolic extract | In vitro | Supersaturated solution of calcium oxalate, kidney epithelial cell lines (MDCK) and urinary bladder of rabbits | ↓ Calcium oxalate crystallization | [ |
| Saponin rich fraction prepared from fruits | In vitro | calcium oxalate crystal nucleation. artificial urine solution | ↓ Calcium oxalate crystal formation | [ | |
| Pomegranate ( | Extract capsule | Clinical | 23 recurrent stone formers (RSFs) and 7 non-stone formers (NSFs) (1000 mg daily) for 90 days | ↓ Serum paraoxonasearylesterase activity | [ |
| Seed | Clinical | 24 patients received | ↓ Recurrence of calcium oxalate stone | [ | |
| A tea bag of dried plant | Clinical | 9 patients with renal stones and 9 with non-renal stone received tea (A cup of tea made from 1.5 g of dry herb two times daily | ↑ Uric acid excretion and clearance | [ |
↑ demonstrates increasing trend; ↓ demonstrates deccreasing trend.
Cellular studies on medicinal plants used for the prevention and treatment of kidney stones.
| Plant | Part or Chemical Constituents | Study Type | Study Design | Results | Reference |
|---|---|---|---|---|---|
| Hydro-alcoholic extract of rhizomes | In vitro | Calcium oxalate induced in a synthetic urine system | ↑ Nucleation and aggregation of COM crystals | [ | |
| Aqueous-methanolic extract of rhizome | In vitro | Calcium oxalate induced crystal in a synthetic urine system | Inhibition of crystal aggregation and formation | [ | |
| Extract | In vitro | Struvite crystals induced using gel growth technique | ↓ Growth and the size of the struvite crystals | [ | |
| Aqueous dried plant extract | In vitro | Calcium oxalate monohydrate (COM) crystals induced in MDCK cells | ↓ Crystal growth and calculogenesis | [ | |
| Ether and methanol extracts of aerial parts | In vitro | Calcium oxalate-induced stone in urine | ↓ The size and supersaturation rate of crystals | [ | |
| Aqueous fruits extract | In vitro | Calcium oxalate induced cell injury in NRK-52E and MDCK renal epithelial cells | ↓ Lactate dehydrogenase release | [ | |
| Protein biomolecules | In vitro | Oxalate induced injury on NRK-52E cells | ↓ Lactate dehydrogenase release | [ |
↑ demonstrates increasing trend; ↓ demonstrates deccreasing trend.
Pre-clinical and clinical evidence on medicinal plants used for prevention and treatment of kidney stones.
| Plant | Part or Chemical Constituents | Study Type | Study Design | Results | Reference |
|---|---|---|---|---|---|
| Ethanolic extract | In vivo | Ethylene glycol (EG)-induced urolithiasis in Wistar albino rats | ↑ Ca2+ ATPase, Mg2+ ATPase, Na+K+ ATPase | [ | |
| Aqueous suspension of aerial parts | In vivo | EG-induced urolithiasis in rats | ↓ Glycolic acid oxidase (GAO), and lactate dehydrogenase (LDH) | [ | |
| Hydroalcolohlic extract of whole plant | In vivo | EG-induced urolithiasis in rats | ↓ Stone forming constituents, Blood urea nitrogen (BUN), uric acid and creatinine | [ | |
| Hydroalcoholic extract of roots | In vivo | EG-induced lithiasis in rats | ↓ The number of calcium oxalate deposits | [ | |
| Ethanolic extract of tuberous roots | In vivo | EG-induced urolithiasis in rats | ↓ The level of calcium, oxalate, phosphate, and serum creatinine; ↑ Urinary concentration of magnesium | [ | |
| The hydro-methanolic extract of rhizomes | In vivo | EG-induced urolithiasis in rats | ↓ Nucleation and aggregation of crystals | [ | |
| Aqueous-methanolic extract of rhizome | In vivo | EG-induced urolithiasis in rats | ↓ Calcium oxalate crystal deposition, and lithogenic signs | [ | |
| Ethanolic extract of rhizome; bergenin | In vivo | EG+ aluminium chloride-induced urolithiasis in rats | ↓ MDA level, | [ | |
| Fruit aqueous and ethanol extract | In vivo | EG-induced urolithiasis in rats | ↓ Urinary oxalate | [ | |
| Commercial herbal powder- gastric gavage | In vivo | EG-induced stones in rats | ↓ Deposition of calcium oxalate crystal | [ | |
| N-butanol and ethyl acetate extract of root | In vivo | EG-induced calculus in rats | Preventing calcium oxalate deposition | [ | |
| Capitulum aqueous extract | In vivo | Sodium oxalate- induced urolithiasis in rats | ↓ Formation and growth of crystals | [ | |
| Seeds ethanolic extract | In vivo | EG-induced urolithiasis in rats | ↓ Stone forming constituents | [ | |
| Methanolic extract of aerial parts | In vivo | EG-induced nephrolithiasis in rats | ↓ Urinary oxalate | [ | |
| Hydroalcoholic extract of leaves | In vivo | EG+ ammonium chloride- induced stone in rats | ↓ The size and number of calcium oxalate deposits | [ | |
| Methanolic extract of leaves | In vivo | EG-induced urolithiasis in rats | ↓ Urinary calcium, oxalate and phosphate excretion | [ | |
| Ethanolic extract of spore | In vivo | EG-induced kidney calculi in rats | ↓ Urinary calcium, oxalate and uric acid | [ | |
| Aqueous extract of leaves | In vivo | EG-induced stones in rats | ↓ Crystal deposits | [ | |
| Butanolic extract of aerial parts | In vivo | Sodium oxalate-induced lithiasis in rats | ↓ Renal necrosis | [ | |
| Whole-plant hydroalcoholic extract | In vivo | EG- induced kidney stone in rats | ↓ Serum urea nitrogen, creatinine and uric acid levels | [ | |
| Leaves aqueous extract | In vivo | EG and the vitamin D3 analog(α-calcidol)-induced urolithiasis in rats | ↓ MDA and serum creatinine level | [ | |
| Aqueous and alcoholic extract of the leaves | In vivo | EG- induced urolithiasis in rats | ↓ Urinary oxalate levels and deposition | [ | |
| Chloroform extract of the plant | In vivo | EG and ammonium chloride- induced urolithiasis in rats | ↑ Urinary flow rate, glomerular filtration rate (GFR) | [ | |
| Extract | Clinical | Unblinded treatment to the patients (treatment group received potassium citrate + | ↓ Number and size of urinary stones | [ | |
| Extract | Clinical | 150 patients received 1 to 3 extracorporeal shock wave lithotripsy sessions. After treatment 78 patients received extract and 72 were served as a control group (2 g/day for 3 month) | ↑ Stone-free rate (stone-free defined as the absence of any stone or residual fragments less than 3 mm) | [ |
↑ demonstrates increasing trend; ↓ demonstrates deccreasing trend.
Cellular and animal evidence on phytochemicals used for prevention and treatment of kidney stones.
| Photochemical | In Vitro/In Vivo | Model | Result | Reference |
|---|---|---|---|---|
| Catechin | In vitro | Calcium oxalate monohydrate(COM)-induced NRK-52E cells | ↑ SOD activity | [ |
| In vivo | Ethylene glycol (EG) induced nephrolithiasis in rat | ↑ OPN, | [ | |
| In vivo | EG-induced nephrolithiasis in rat | ↓ Calcium oxalate monohydrate and Papillary calculus formation | [ | |
| Epigallocatechin-3-gallate | In vitro | COM-induced Madin–Darby canine kidney (MDCK) cells | ↓ α-enolase protein expression | [ |
| In vitro | Oxalate-induced NRK-52E cells | ↓ Free-radical production | [ | |
| In vivo | Oxalate-induced renal stone in rats | ↓ Excretion of urinary oxalate | [ | |
| Diosmin | In vivo | EG-induced nephrolithiasis in rat | ↓ Capillary hyper-permeability | [ |
| Rutin | In vivo | EG-induced nephrolithiasis in rat | Prevention of stone formation | [ |
| Quercetin | In vivo | EG induced calcium oxalate (CaOx) formation | Hypo-Uricemic, and anti-inflammatory activities | [ |
| In vitro | Sodium oxalate | ↓ Cell viability | [ | |
| In vivo | Hyperoxaluria-induced rats | ↓ Urinary crystal deposit formation | [ | |
| In vivo | EG-induced nephrolithiasis in rat | ↓ Oxidative damage | [ |
↑ demonstrates increasing trend; ↓ demonstrates deccreasing trend.
Figure 1Main mechanisms of action of dietary polyphenols in the prevention of kidney stones (Up arrow demonstrates increasing trend; down arrow demonstrates decreasing trend).